Future Planet Capital

Founded in London in 2016, Future Planet Capital is a venture capital firm investing in growth-stage companies from top global universities. It focuses on breakthrough technologies addressing challenges in climate change, health, education, and sustainable growth.

Daniel Gaize

Investment Executive

Douglas Hansen-Luke

Executive Chairman

Sakura Holloway

Investment Director

David Knox

Founding Director and Shareholder

Alexander Leigh

Investment Director

Past deals in England

Mach42

Seed Round in 2023
Machine Discovery is a spin-out from the University of Oxford focused on commercializing advanced machine learning technology. The company has developed a simulation management platform that utilizes proprietary neural network technology to enhance the efficiency of compute-intensive tasks. This platform enables clients to conduct simulations with minimal data input while achieving a high level of accuracy, specifically 99.9% fidelity. By accelerating costly calculations, Machine Discovery provides valuable statistical insights that aid clients in speeding up their innovation processes, thus addressing critical demands in various sectors.

Halo X Ray Technologies

Series A in 2023
HALO X-ray Technologies has been spun out of the Imaging Science Group at Nottingham Trent University and the Cranfield Forensic Institute at Cranfield University. We are developing commercially-focused OEM X-ray diffraction solutions based on novel and patented Focal Construct Technology that provides platform capability across a wide range of application areas. Their initial focus lies in the development of HALO solutions for the aviation security and the medical systems markets. We have strong ties to the aviation sector through a long and prestigious research and development programme that has previously realised novel divergent beam X-ray technology (developed and marketed through various incumbent suppliers such as 3DX-ray Ltd) and kinetic depth systems (developed and marketed through Astrophyscis Inc) as 3rd party solutions. We have a clear focus on medical systems and we are currently part of a consortium recentlly awarded an EPSRC grant on Point-of-Care High Accuracy Fracture Risk Prediction. This is an exciting project and we look forward to working with our partners in developing HALO technology for this market.

CHAIN Biotechnology

Seed Round in 2023
CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Inition

Seed Round in 2023
Inition decarbonizes battery production and makes it accessible to all levels of the industry. Inition was founded in Didcot, England.

Vitarka Therapeutics

Seed Round in 2023
Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

RoadHow

Funding Round in 2022
RoadHow is a technology company based in Solihull, United Kingdom, founded in 2019. It specializes in driver risk management and education through its innovative online platform. This platform allows drivers to assess their driving knowledge while providing opportunities for further learning. RoadHow's offerings include data-compliant engagement tools that facilitate advertising, messaging, and marketing, aimed at helping clients enhance their operational efficiency. By leveraging these capabilities, the company supports clients in improving loss ratios, reducing incident frequency, and increasing retention rates among drivers.

RIPE Building Services

Series B in 2022
RIPE Building Services is a building design firm headquartered in Melton Mowbray, England, that specializes in consultative, construction, and comprehensive project management services. The company focuses on providing environmentally conscious solutions tailored to enhance commercial productivity. By offering a diverse array of services, RIPE Building Services assists businesses and horticulturists in maximizing their yield through sustainable practices, ensuring both efficiency and environmental responsibility in their projects.

Beam

Series B in 2022
Rovco Ltd is a company based in Bristol, United Kingdom, specializing in underwater hydrographic survey and inspection services through the use of remotely operated vehicles (ROVs) and autonomous underwater vehicles (AUVs). Founded in 2015, Rovco serves clients in the oil, gas, and renewable energy sectors by offering advanced technologies that enhance the management and inspection of subsea assets. The company's innovative solutions include 3D photogrammetry, which creates detailed 3D models from high-resolution photographs, allowing clients to assess their assets for damage, corrosion, and marine growth. By leveraging artificial intelligence and machine learning, Rovco provides autonomous subsea robotics and advanced inspection capabilities, enabling clients to make informed engineering decisions and undertake preventative maintenance, thereby reducing project risks and costs.

Your Vets

Convertible Note in 2022
Your Vets is a UK-based network of veterinary clinics delivering affordable preventive care for pets. The group operates multiple practices across locations including Wythall, Coventry, Nuneaton, Stetchford, Rayleigh and Dagenham, offering vaccinations, neutering and general veterinary services to a broad client base.

Diverse School Travel

Convertible Note in 2022
A UK-based educational tour operator specializing in cultural and historical trips for schools and colleges across Europe. Headquartered in Birmingham, their multilingual team focuses on delivering high-quality experiences at competitive prices.

Igloo Vision

Convertible Note in 2022
Igloo Vision Limited specializes in immersive 360º projection technologies designed for various applications, including simulation, visualization, and collaborative experiences. The company creates virtual reality tools such as media players, software interfaces, projector rigs, and a range of projection environments including domes and cylinders. These immersive spaces allow groups to engage with digital content, making them ideal for entertainment, teamwork, training, and data visualization. Established in 2008 and headquartered in Craven Arms, United Kingdom, Igloo Vision has built a reputation over its decade-long history by collaborating with major global brands and delivering numerous installations and events worldwide. The company's innovative approach transforms any digital content into a shared immersive experience, enhancing the way teams collaborate and visualize complex information.

MicrofluidX

Funding Round in 2022
MicrofluidX Ltd is a London-based company established in 2018 that specializes in developing a cell bioprocessing platform specifically designed for autologous cell and gene therapy manufacturing. The company offers a microfluidic bioprocessing system that integrates various cell culture capabilities—including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting—into a single closed system. This automated technology addresses key challenges in the field, such as process control, scalability, and cost, enabling biologists to efficiently conduct process development by experimenting with multiple cell culture conditions.

Utility Stream

Funding Round in 2022
Utility Stream Limited, established in 2018 and headquartered in Warwick, United Kingdom, specializes in utility procurement and renewable energy consultancy services. The company focuses on providing gas, electricity, and water procurement, along with a range of technology services aimed at enhancing energy efficiency. Its offerings include energy intelligence, voltage optimization, metering, and pipework services. Utility Stream also delivers comprehensive bureau services such as account management, bill validation, contract management, and multilingual support. By implementing tailored energy management strategies, Utility Stream assists businesses in reducing their energy consumption and carbon footprint while optimizing costs.

Navenio

Venture Round in 2021
Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.

The Smarter Food Company

Equity Crowdfunding in 2021
The Smarter Food Company focuses on developing foods with proven health benefits. The Smarter Food Company was founded in 2019 and was headquartered in Norwich, England.

Online Poundshop

Series A in 2021
Online Poundshop Ltd is an online retailer that specializes in providing a wide array of household essentials at a single price point, offering convenience for customers seeking affordable shopping options. Established in February 2014 and headquartered in Brierley Hill, United Kingdom, the company provides a diverse selection of products, including clothing, watches, jewelry, groceries, personal care items, DIY and garden supplies, baby and pet products, arts and crafts, and various household goods. Online Poundshop serves customers across several European countries, including the United Kingdom, Spain, France, Ireland, Germany, Belgium, the Netherlands, Luxembourg, and Portugal. The company aims to make everyday essentials accessible through its 24-hour online platform, allowing for convenient home delivery of its extensive product range.

Inition

Convertible Note in 2021
Inition decarbonizes battery production and makes it accessible to all levels of the industry. Inition was founded in Didcot, England.

Utility Stream

Funding Round in 2021
Utility Stream Limited, established in 2018 and headquartered in Warwick, United Kingdom, specializes in utility procurement and renewable energy consultancy services. The company focuses on providing gas, electricity, and water procurement, along with a range of technology services aimed at enhancing energy efficiency. Its offerings include energy intelligence, voltage optimization, metering, and pipework services. Utility Stream also delivers comprehensive bureau services such as account management, bill validation, contract management, and multilingual support. By implementing tailored energy management strategies, Utility Stream assists businesses in reducing their energy consumption and carbon footprint while optimizing costs.

Natural HR

Convertible Note in 2021
Natural HR Limited is a developer of human resources management software based in Rugby, United Kingdom, established in 2010. The company offers an online employee management system tailored to support businesses in managing remote employees, particularly those who need to submit timesheets weekly. Its platform provides a comprehensive suite of tools that streamline various HR functions, including employee data management, time-off tracking, training, and performance evaluations. Designed to simplify and automate human capital processes, Natural HR's cloud-based solution allows organizations to manage hiring activities and make informed decisions from a centralized system. The company addresses a specific market need for reliable and cost-effective HR software, focusing on user experience and customer support to continually enhance its offerings.

AgPlus Diagnostics

Seed Round in 2021
AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

Midven

Acquisition in 2021
Midven, established in 1990 and headquartered in Birmingham, UK, is a venture capital firm specialising in early-stage and growth-stage investments. It focuses on providing up to £1 million to fast-growing small and medium-sized enterprises (SMEs), supporting their expansion and development. Midven's team, comprising experienced and hands-on investment managers, offers not only capital but also strategic guidance to its portfolio companies.

RIPE Building Services

Series A in 2021
RIPE Building Services is a building design firm headquartered in Melton Mowbray, England, that specializes in consultative, construction, and comprehensive project management services. The company focuses on providing environmentally conscious solutions tailored to enhance commercial productivity. By offering a diverse array of services, RIPE Building Services assists businesses and horticulturists in maximizing their yield through sustainable practices, ensuring both efficiency and environmental responsibility in their projects.

Halo X Ray Technologies

Convertible Note in 2021
HALO X-ray Technologies has been spun out of the Imaging Science Group at Nottingham Trent University and the Cranfield Forensic Institute at Cranfield University. We are developing commercially-focused OEM X-ray diffraction solutions based on novel and patented Focal Construct Technology that provides platform capability across a wide range of application areas. Their initial focus lies in the development of HALO solutions for the aviation security and the medical systems markets. We have strong ties to the aviation sector through a long and prestigious research and development programme that has previously realised novel divergent beam X-ray technology (developed and marketed through various incumbent suppliers such as 3DX-ray Ltd) and kinetic depth systems (developed and marketed through Astrophyscis Inc) as 3rd party solutions. We have a clear focus on medical systems and we are currently part of a consortium recentlly awarded an EPSRC grant on Point-of-Care High Accuracy Fracture Risk Prediction. This is an exciting project and we look forward to working with our partners in developing HALO technology for this market.

Cytoseek

Seed Round in 2021
Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

Linear Diagnostics

Venture Round in 2021
Linear Diagnostics develops a proprietary diagnostic platform technology that enables rapid, simultaneous detection of multiple targets using a single reagent. Its core innovation, linear dichroism, facilitates molecular diagnostics tests across various sectors, including infectious diseases and food safety.

CFP Composites

Convertible Note in 2021
CFP Composites Ltd (formerly known as Carbon Fibre Preforms) is based in Dudley in the West Midlands, operating from a 28,000 square foot factory configured on a modular basis allowing for low-cost, rapid expansion. Offering a unique range of carbon fibre composite materials for extreme high temperature applications. CFP Composites’ technology enables composite materials to be produced significantly quicker, making the materials a commercially viable alternative to metal solutions.

RoadHow

Seed Round in 2021
RoadHow is a technology company based in Solihull, United Kingdom, founded in 2019. It specializes in driver risk management and education through its innovative online platform. This platform allows drivers to assess their driving knowledge while providing opportunities for further learning. RoadHow's offerings include data-compliant engagement tools that facilitate advertising, messaging, and marketing, aimed at helping clients enhance their operational efficiency. By leveraging these capabilities, the company supports clients in improving loss ratios, reducing incident frequency, and increasing retention rates among drivers.

Congenica

Series C in 2020
Congenica Ltd. is a biotechnology company that specializes in clinical data solutions for genetic diagnosis. Established in 2012 and headquartered in Hinxton, United Kingdom, it offers the Sapientia platform, a clinical genomic analytics tool that integrates human DNA sequences with deep clinical phenotyping. This platform enables clinicians and researchers to interpret genetic diseases and provides actionable insights for diagnosis, prognosis, and research. Additionally, Sapientia supports personalized medicine by facilitating the creation of disease registries, identifying patient populations for clinical studies, and aiding in the discovery of novel drug targets and biomarkers. Congenica's focus is on improving clinical outcomes through advanced genomic analysis.

D-RisQ

Venture Round in 2020
D-RisQ is a UK-based software verification company established in 2011 and headquartered in Malvern. It specializes in automated tools that enhance system safety across industries such as aerospace, automotive, and security. The company develops Kapture, a tool that allows software requirements to be written in clear, verifiable form, and Modelworks, which enables automatic verification of designs in Simulink and Stateflow. By applying formal methods and mathematical techniques, D-RisQ automates the verification process from design to object code, reducing reliance on extensive manual testing and helping organizations meet regulatory standards more efficiently. The tools are designed to lower development costs and shorten time to deployment while providing verifiable assurance of software behavior for critical systems.

Navenio

Series A in 2020
Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.

Utility Stream

Venture Round in 2020
Utility Stream Limited, established in 2018 and headquartered in Warwick, United Kingdom, specializes in utility procurement and renewable energy consultancy services. The company focuses on providing gas, electricity, and water procurement, along with a range of technology services aimed at enhancing energy efficiency. Its offerings include energy intelligence, voltage optimization, metering, and pipework services. Utility Stream also delivers comprehensive bureau services such as account management, bill validation, contract management, and multilingual support. By implementing tailored energy management strategies, Utility Stream assists businesses in reducing their energy consumption and carbon footprint while optimizing costs.

AgPlus Diagnostics

Grant in 2020
AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

Keit

Funding Round in 2020
Keit Ltd. is a company specializing in the design and manufacture of advanced spectrometers and related instruments, catering to a wide range of applications from ultraviolet to far infrared rays. Incorporated in 2012 and headquartered in Didcot, United Kingdom, Keit is known for its innovative microFTS® design, a Fourier Transform Infrared (FTIR) spectrometer that is notably smaller, lighter, and more rugged than existing systems. Originally developed for space applications, the microFTS® is capable of operating in extreme environments and sets a new standard for real-time liquid-state analyses across various industries, including Pharmaceutical, Chemical, Oil & Gas, and Food & Beverage. Keit's products are also utilized for measuring signal levels, near line vibrations, and analyzing gas or liquid-borne species.

Navenio

Series A in 2020
Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.

Oxford Advanced Surfaces Group

Funding Round in 2020
Oxford Advanced Surfaces Group Plc is a company that focuses on surface modification. When it comes to surface modification, we are the experts. As a team we have over 70 years of experience and over 30 patents in this field since our commercialisation out of the University of Oxford. Our team of scientists is highly skilled in the synthesis and formulation of Onto™ materials, so we design and optimise products to meet the needs of real industrial challenges.

MicrofluidX

Seed Round in 2020
MicrofluidX Ltd is a London-based company established in 2018 that specializes in developing a cell bioprocessing platform specifically designed for autologous cell and gene therapy manufacturing. The company offers a microfluidic bioprocessing system that integrates various cell culture capabilities—including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting—into a single closed system. This automated technology addresses key challenges in the field, such as process control, scalability, and cost, enabling biologists to efficiently conduct process development by experimenting with multiple cell culture conditions.

CFP Composites

Series A in 2020
CFP Composites Ltd (formerly known as Carbon Fibre Preforms) is based in Dudley in the West Midlands, operating from a 28,000 square foot factory configured on a modular basis allowing for low-cost, rapid expansion. Offering a unique range of carbon fibre composite materials for extreme high temperature applications. CFP Composites’ technology enables composite materials to be produced significantly quicker, making the materials a commercially viable alternative to metal solutions.

Luffy AI

Funding Round in 2020
Luffy AI is a technology company that creates adaptive neural networks for edge and embedded applications. Its solutions include an AI flight controller for unmanned aerial vehicles and an intelligent actuator controller for robotics and industrial processes. The company’s core approach is neuroplasticity, enabling models to continuously retrain in real‑time using feedback from the operating environment and user‑defined goals. This allows businesses to optimize complex operations with greater efficiency, resilience, and sustainability. Founded in 2018 and headquartered in Thame, United Kingdom, Luffy AI focuses on delivering real‑time, self‑learning intelligence that adapts to changing conditions without requiring offline retraining.

Cytoseek

Seed Round in 2019
Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

Linear Diagnostics

Venture Round in 2019
Linear Diagnostics develops a proprietary diagnostic platform technology that enables rapid, simultaneous detection of multiple targets using a single reagent. Its core innovation, linear dichroism, facilitates molecular diagnostics tests across various sectors, including infectious diseases and food safety.

Ultromics

Funding Round in 2019
Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. By leveraging artificial intelligence, the company has created highly accurate diagnostic tools that improve the identification of coronary artery disease, achieving diagnostic accuracy improvements of over 90%. Ultromics' technology processes complex data from electrocardiograms, empowering healthcare providers to make informed clinical decisions and ultimately enhancing patient care in cardiology.

AgPlus Diagnostics

Funding Round in 2019
AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

CHAIN Biotechnology

Funding Round in 2019
CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Quantum Group

Funding Round in 2019
Quantum Group Solutions Limited, based in Knowle, Solihull, United Kingdom, specializes in recruitment services, including outplacement and employment vacancy listing. The company assists organizations by referring applicants for various positions, ensuring that the individuals referred are not employees of the employment agencies. Founded in 2000 and originally named Quantum Search & Selection Limited, the company rebranded in January 2010 to reflect its broader service offerings.

Online Poundshop

Series A in 2019
Online Poundshop Ltd is an online retailer that specializes in providing a wide array of household essentials at a single price point, offering convenience for customers seeking affordable shopping options. Established in February 2014 and headquartered in Brierley Hill, United Kingdom, the company provides a diverse selection of products, including clothing, watches, jewelry, groceries, personal care items, DIY and garden supplies, baby and pet products, arts and crafts, and various household goods. Online Poundshop serves customers across several European countries, including the United Kingdom, Spain, France, Ireland, Germany, Belgium, the Netherlands, Luxembourg, and Portugal. The company aims to make everyday essentials accessible through its 24-hour online platform, allowing for convenient home delivery of its extensive product range.

Halo X Ray Technologies

Venture Round in 2019
HALO X-ray Technologies has been spun out of the Imaging Science Group at Nottingham Trent University and the Cranfield Forensic Institute at Cranfield University. We are developing commercially-focused OEM X-ray diffraction solutions based on novel and patented Focal Construct Technology that provides platform capability across a wide range of application areas. Their initial focus lies in the development of HALO solutions for the aviation security and the medical systems markets. We have strong ties to the aviation sector through a long and prestigious research and development programme that has previously realised novel divergent beam X-ray technology (developed and marketed through various incumbent suppliers such as 3DX-ray Ltd) and kinetic depth systems (developed and marketed through Astrophyscis Inc) as 3rd party solutions. We have a clear focus on medical systems and we are currently part of a consortium recentlly awarded an EPSRC grant on Point-of-Care High Accuracy Fracture Risk Prediction. This is an exciting project and we look forward to working with our partners in developing HALO technology for this market.

PolyProx

Seed Round in 2019
PolyProx Therapeutics Ltd is a biotechnology company based in Cambridge, United Kingdom, founded in 2018. It focuses on researching and developing innovative drug therapies aimed at treating cancer and neurodegenerative diseases. The company's flagship product, Polyproxin, utilizes engineered proteins that selectively target tumor cells. This mechanism activates the natural degradation processes within the cells, allowing for the removal of disease-causing proteins. By employing this novel approach, PolyProx aims to provide effective treatment options for cancer patients, potentially improving their outcomes and quality of life.

Congenica

Series B in 2019
Congenica Ltd. is a biotechnology company that specializes in clinical data solutions for genetic diagnosis. Established in 2012 and headquartered in Hinxton, United Kingdom, it offers the Sapientia platform, a clinical genomic analytics tool that integrates human DNA sequences with deep clinical phenotyping. This platform enables clinicians and researchers to interpret genetic diseases and provides actionable insights for diagnosis, prognosis, and research. Additionally, Sapientia supports personalized medicine by facilitating the creation of disease registries, identifying patient populations for clinical studies, and aiding in the discovery of novel drug targets and biomarkers. Congenica's focus is on improving clinical outcomes through advanced genomic analysis.

The Smarter Food Company

Convertible Note in 2019
The Smarter Food Company focuses on developing foods with proven health benefits. The Smarter Food Company was founded in 2019 and was headquartered in Norwich, England.

Inivata

Series B in 2019
Inivata Limited is a clinical cancer genomics company based in Cambridge, United Kingdom, that specializes in the analysis of circulating tumor DNA (ctDNA) to enhance cancer testing and treatment. Founded in 2014, Inivata has developed TAm-Seq technology, which enables the detection and analysis of genomic material from a patient's cell-free ctDNA, collected through non-invasive blood samples. This innovative approach, known as liquid biopsy, provides a significant advancement over traditional invasive biopsies by allowing for easier detection, monitoring, and treatment of cancer. Inivata's platform aims to assist oncologists in making informed treatment decisions by improving the understanding of cancer dynamics, including monitoring treatment responses and detecting relapses. The company has established a strategic collaboration with NeoGenomics, Inc. to further its mission in the field of cancer genomics.

Natural HR

Series A in 2019
Natural HR Limited is a developer of human resources management software based in Rugby, United Kingdom, established in 2010. The company offers an online employee management system tailored to support businesses in managing remote employees, particularly those who need to submit timesheets weekly. Its platform provides a comprehensive suite of tools that streamline various HR functions, including employee data management, time-off tracking, training, and performance evaluations. Designed to simplify and automate human capital processes, Natural HR's cloud-based solution allows organizations to manage hiring activities and make informed decisions from a centralized system. The company addresses a specific market need for reliable and cost-effective HR software, focusing on user experience and customer support to continually enhance its offerings.

Pireta

Funding Round in 2018
Pireta Ltd, established in 2017 and headquartered in Teddington, UK, specializes in developing and commercializing smart textile technology. The company's core business involves creating an additive process that imparts conductivity and sensors to fabrics at any stage of manufacturing, without altering their handle or drape. Pireta's innovative textiles are used across various industries, including military and defense, healthcare, fashion, athletics, and RFID tagging, enabling communication, physiological measurement tracking, and electronic system integration on a wide range of fabrics.

CFP Composites

Venture Round in 2018
CFP Composites Ltd (formerly known as Carbon Fibre Preforms) is based in Dudley in the West Midlands, operating from a 28,000 square foot factory configured on a modular basis allowing for low-cost, rapid expansion. Offering a unique range of carbon fibre composite materials for extreme high temperature applications. CFP Composites’ technology enables composite materials to be produced significantly quicker, making the materials a commercially viable alternative to metal solutions.

Igloo Vision

Funding Round in 2018
Igloo Vision Limited specializes in immersive 360º projection technologies designed for various applications, including simulation, visualization, and collaborative experiences. The company creates virtual reality tools such as media players, software interfaces, projector rigs, and a range of projection environments including domes and cylinders. These immersive spaces allow groups to engage with digital content, making them ideal for entertainment, teamwork, training, and data visualization. Established in 2008 and headquartered in Craven Arms, United Kingdom, Igloo Vision has built a reputation over its decade-long history by collaborating with major global brands and delivering numerous installations and events worldwide. The company's innovative approach transforms any digital content into a shared immersive experience, enhancing the way teams collaborate and visualize complex information.

CHAIN Biotechnology

Funding Round in 2018
CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Cytoseek

Seed Round in 2018
Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

Ultromics

Series A in 2018
Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. By leveraging artificial intelligence, the company has created highly accurate diagnostic tools that improve the identification of coronary artery disease, achieving diagnostic accuracy improvements of over 90%. Ultromics' technology processes complex data from electrocardiograms, empowering healthcare providers to make informed clinical decisions and ultimately enhancing patient care in cardiology.

Oxford Advanced Surfaces Group

Funding Round in 2018
Oxford Advanced Surfaces Group Plc is a company that focuses on surface modification. When it comes to surface modification, we are the experts. As a team we have over 70 years of experience and over 30 patents in this field since our commercialisation out of the University of Oxford. Our team of scientists is highly skilled in the synthesis and formulation of Onto™ materials, so we design and optimise products to meet the needs of real industrial challenges.

MIRICO

Venture Round in 2018
MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, founded in 2015 as a spin‑out from the STFC Rutherford Appleton Laboratory. It develops high‑performance gas‑sensing products that use laser dispersion, tunable laser absorption, and isotope‑ratio techniques to provide real‑time, in‑situ monitoring of trace gases and isotopologues. The instruments are applied in space exploration, planetary landers, environmental monitoring, atmospheric emissions, geochemistry, medical diagnostics, and oil‑and‑gas exploration and production. The company’s cloud‑connected platform delivers autonomous, continuous measurements in all weather conditions, enabling detection, localisation, and quantification of emissions to support net‑zero targets and operational optimisation.

Eagle Genomics

Venture Round in 2018
Eagle Genomics is a life sciences software company that provides data management and analytics platforms for genomics and related fields. Its solutions enable management, orchestration and exploitation of genomics and other life sciences data, turning diverse datasets into usable data assets and supporting end-to-end workflows from data integration and curation to analysis, visualization and sharing. The company combines biology, bioinformatics, data science, and enterprise software engineering to help pharmaceutical, consumer goods, and agricultural technology organizations shorten research cycles and improve decision making. Its offerings cover next-generation sequencing data management and analysis, cloud-based bioinformatics, biomarker discovery, microarray analysis, and pipeline design, as well as on-demand consulting and tools for managing research data. Headquartered in Cambridge, United Kingdom, with an international footprint, Eagle Genomics emphasizes building an enterprise information architecture for the genomics era, enabling customers to realize the value of digital assets and enhance productivity across R&D programs.

SFH Oxford

Seed Round in 2018
SFH Oxford Ltd. is a UK-based company specializing in the development and marketing of innovative healthcare products aimed at enhancing the management of venous leg ulcers. Founded in 2011 and located in Didcot, the company has created Graducheck, a sensor-based technology that improves the application of compression bandages, thereby increasing healing rates and promoting patient compliance. SFH Oxford also offers anatomic focus technology graduated compression socks, which provide essential graduated compression, and K-gel wound dressings. The company is actively engaged in clinical and field trials for several of its products, which are showing promising results in real-world applications. With a leadership team experienced in medical device technology, wound care, and business development, SFH Oxford is focused on delivering optimized care for patients and healthcare professionals involved in ulcer management.

AgPlus Diagnostics

Funding Round in 2018
AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

Navenio

Seed Round in 2017
Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.

Pireta

Seed Round in 2017
Pireta Ltd, established in 2017 and headquartered in Teddington, UK, specializes in developing and commercializing smart textile technology. The company's core business involves creating an additive process that imparts conductivity and sensors to fabrics at any stage of manufacturing, without altering their handle or drape. Pireta's innovative textiles are used across various industries, including military and defense, healthcare, fashion, athletics, and RFID tagging, enabling communication, physiological measurement tracking, and electronic system integration on a wide range of fabrics.

CHAIN Biotechnology

Grant in 2017
CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

AgPlus Diagnostics

Grant in 2017
AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

Cytox

Series B in 2017
Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

Linear Diagnostics

Seed Round in 2017
Linear Diagnostics develops a proprietary diagnostic platform technology that enables rapid, simultaneous detection of multiple targets using a single reagent. Its core innovation, linear dichroism, facilitates molecular diagnostics tests across various sectors, including infectious diseases and food safety.

ZuvaSyntha

Funding Round in 2017
ZuvaSyntha Limited is an industrial biotechnology company based in Welwyn Garden City, United Kingdom, founded in 2011. The company specializes in developing innovative bio-routes for the production of renewable chemicals from C1 feedstocks. ZuvaSyntha offers a range of contract research and development services, including product and process development, metabolite synthesis, biocatalysis, metabolic pathway engineering, and fermentation. Initially incorporated as BioSyntha Technology Ltd., the company rebranded to ZuvaSyntha Limited in May 2015 and currently operates as a subsidiary of ZuvaChem, Inc.

Congenica

Series B in 2017
Congenica Ltd. is a biotechnology company that specializes in clinical data solutions for genetic diagnosis. Established in 2012 and headquartered in Hinxton, United Kingdom, it offers the Sapientia platform, a clinical genomic analytics tool that integrates human DNA sequences with deep clinical phenotyping. This platform enables clinicians and researchers to interpret genetic diseases and provides actionable insights for diagnosis, prognosis, and research. Additionally, Sapientia supports personalized medicine by facilitating the creation of disease registries, identifying patient populations for clinical studies, and aiding in the discovery of novel drug targets and biomarkers. Congenica's focus is on improving clinical outcomes through advanced genomic analysis.

Eagle Genomics

Venture Round in 2016
Eagle Genomics is a life sciences software company that provides data management and analytics platforms for genomics and related fields. Its solutions enable management, orchestration and exploitation of genomics and other life sciences data, turning diverse datasets into usable data assets and supporting end-to-end workflows from data integration and curation to analysis, visualization and sharing. The company combines biology, bioinformatics, data science, and enterprise software engineering to help pharmaceutical, consumer goods, and agricultural technology organizations shorten research cycles and improve decision making. Its offerings cover next-generation sequencing data management and analysis, cloud-based bioinformatics, biomarker discovery, microarray analysis, and pipeline design, as well as on-demand consulting and tools for managing research data. Headquartered in Cambridge, United Kingdom, with an international footprint, Eagle Genomics emphasizes building an enterprise information architecture for the genomics era, enabling customers to realize the value of digital assets and enhance productivity across R&D programs.

AgPlus Diagnostics

Venture Round in 2016
AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

Keit

Venture Round in 2016
Keit Ltd. is a company specializing in the design and manufacture of advanced spectrometers and related instruments, catering to a wide range of applications from ultraviolet to far infrared rays. Incorporated in 2012 and headquartered in Didcot, United Kingdom, Keit is known for its innovative microFTS® design, a Fourier Transform Infrared (FTIR) spectrometer that is notably smaller, lighter, and more rugged than existing systems. Originally developed for space applications, the microFTS® is capable of operating in extreme environments and sets a new standard for real-time liquid-state analyses across various industries, including Pharmaceutical, Chemical, Oil & Gas, and Food & Beverage. Keit's products are also utilized for measuring signal levels, near line vibrations, and analyzing gas or liquid-borne species.

Pireta

Funding Round in 2016
Pireta Ltd, established in 2017 and headquartered in Teddington, UK, specializes in developing and commercializing smart textile technology. The company's core business involves creating an additive process that imparts conductivity and sensors to fabrics at any stage of manufacturing, without altering their handle or drape. Pireta's innovative textiles are used across various industries, including military and defense, healthcare, fashion, athletics, and RFID tagging, enabling communication, physiological measurement tracking, and electronic system integration on a wide range of fabrics.

MIRICO

Seed Round in 2016
MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, founded in 2015 as a spin‑out from the STFC Rutherford Appleton Laboratory. It develops high‑performance gas‑sensing products that use laser dispersion, tunable laser absorption, and isotope‑ratio techniques to provide real‑time, in‑situ monitoring of trace gases and isotopologues. The instruments are applied in space exploration, planetary landers, environmental monitoring, atmospheric emissions, geochemistry, medical diagnostics, and oil‑and‑gas exploration and production. The company’s cloud‑connected platform delivers autonomous, continuous measurements in all weather conditions, enabling detection, localisation, and quantification of emissions to support net‑zero targets and operational optimisation.

Igloo Vision

Convertible Note in 2016
Igloo Vision Limited specializes in immersive 360º projection technologies designed for various applications, including simulation, visualization, and collaborative experiences. The company creates virtual reality tools such as media players, software interfaces, projector rigs, and a range of projection environments including domes and cylinders. These immersive spaces allow groups to engage with digital content, making them ideal for entertainment, teamwork, training, and data visualization. Established in 2008 and headquartered in Craven Arms, United Kingdom, Igloo Vision has built a reputation over its decade-long history by collaborating with major global brands and delivering numerous installations and events worldwide. The company's innovative approach transforms any digital content into a shared immersive experience, enhancing the way teams collaborate and visualize complex information.

ZuvaSyntha

Funding Round in 2016
ZuvaSyntha Limited is an industrial biotechnology company based in Welwyn Garden City, United Kingdom, founded in 2011. The company specializes in developing innovative bio-routes for the production of renewable chemicals from C1 feedstocks. ZuvaSyntha offers a range of contract research and development services, including product and process development, metabolite synthesis, biocatalysis, metabolic pathway engineering, and fermentation. Initially incorporated as BioSyntha Technology Ltd., the company rebranded to ZuvaSyntha Limited in May 2015 and currently operates as a subsidiary of ZuvaChem, Inc.

Diverse School Travel

Funding Round in 2015
A UK-based educational tour operator specializing in cultural and historical trips for schools and colleges across Europe. Headquartered in Birmingham, their multilingual team focuses on delivering high-quality experiences at competitive prices.

Eagle Genomics

Funding Round in 2015
Eagle Genomics is a life sciences software company that provides data management and analytics platforms for genomics and related fields. Its solutions enable management, orchestration and exploitation of genomics and other life sciences data, turning diverse datasets into usable data assets and supporting end-to-end workflows from data integration and curation to analysis, visualization and sharing. The company combines biology, bioinformatics, data science, and enterprise software engineering to help pharmaceutical, consumer goods, and agricultural technology organizations shorten research cycles and improve decision making. Its offerings cover next-generation sequencing data management and analysis, cloud-based bioinformatics, biomarker discovery, microarray analysis, and pipeline design, as well as on-demand consulting and tools for managing research data. Headquartered in Cambridge, United Kingdom, with an international footprint, Eagle Genomics emphasizes building an enterprise information architecture for the genomics era, enabling customers to realize the value of digital assets and enhance productivity across R&D programs.

Cytox

Grant in 2015
Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

ZuvaSyntha

Funding Round in 2015
ZuvaSyntha Limited is an industrial biotechnology company based in Welwyn Garden City, United Kingdom, founded in 2011. The company specializes in developing innovative bio-routes for the production of renewable chemicals from C1 feedstocks. ZuvaSyntha offers a range of contract research and development services, including product and process development, metabolite synthesis, biocatalysis, metabolic pathway engineering, and fermentation. Initially incorporated as BioSyntha Technology Ltd., the company rebranded to ZuvaSyntha Limited in May 2015 and currently operates as a subsidiary of ZuvaChem, Inc.

CHAIN Biotechnology

Seed Round in 2015
CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Diverse School Travel

Funding Round in 2014
A UK-based educational tour operator specializing in cultural and historical trips for schools and colleges across Europe. Headquartered in Birmingham, their multilingual team focuses on delivering high-quality experiences at competitive prices.

Etive

Series A in 2014
Etive Technologies Limited specializes in providing digital data handling solutions focused on personal and property information through a range of web-based log book products. The company's offerings include the Digital Log Book, which helps individuals create a digital identity, and the Home Log Book, designed to enhance the buying process for new home developers by providing essential information and improving post-occupancy customer service. Additionally, the Energy Log Book allows users to monitor and manage home energy consumption. Etive serves a diverse clientele, including local authorities, housing associations, new home builders, healthcare providers, financial service companies, and estate agencies. Founded in 2011 and based in Edinburgh, with an additional office in Birmingham, the company was previously known as Home Log Book Solutions Limited before rebranding in December 2013.

Clinical Insights

Funding Round in 2014
Clinical Insights Limited, established in 2012, is a Milan-based company operating as a subsidiary of CMC Consulting Boston Inc. It specializes in providing data analytics and predictive analysis services tailored for healthcare companies, particularly pharmaceutical firms. The company's core offerings include tools and business advisory services that leverage sophisticated analyses of real-time big data to optimize performance, enhance market insights, and improve overall business efficiency. Clinical Insights Limited helps clients uncover hidden product flows, smooth out demand volatility, refine messaging strategies, and gain deeper insights into patient treatment patterns by embedding analytical techniques and proprietary market information into users' management systems. The company maintains offices in Coventry (UK), Milano (Italy), Athens (Greece), and San Gwann (Malta).

Cytox

Series A in 2014
Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

Your Vets

Convertible Note in 2013
Your Vets is a UK-based network of veterinary clinics delivering affordable preventive care for pets. The group operates multiple practices across locations including Wythall, Coventry, Nuneaton, Stetchford, Rayleigh and Dagenham, offering vaccinations, neutering and general veterinary services to a broad client base.

ZuvaSyntha

Funding Round in 2013
ZuvaSyntha Limited is an industrial biotechnology company based in Welwyn Garden City, United Kingdom, founded in 2011. The company specializes in developing innovative bio-routes for the production of renewable chemicals from C1 feedstocks. ZuvaSyntha offers a range of contract research and development services, including product and process development, metabolite synthesis, biocatalysis, metabolic pathway engineering, and fermentation. Initially incorporated as BioSyntha Technology Ltd., the company rebranded to ZuvaSyntha Limited in May 2015 and currently operates as a subsidiary of ZuvaChem, Inc.

Diverse School Travel

Seed Round in 2013
A UK-based educational tour operator specializing in cultural and historical trips for schools and colleges across Europe. Headquartered in Birmingham, their multilingual team focuses on delivering high-quality experiences at competitive prices.

Eagle Genomics

Seed Round in 2013
Eagle Genomics is a life sciences software company that provides data management and analytics platforms for genomics and related fields. Its solutions enable management, orchestration and exploitation of genomics and other life sciences data, turning diverse datasets into usable data assets and supporting end-to-end workflows from data integration and curation to analysis, visualization and sharing. The company combines biology, bioinformatics, data science, and enterprise software engineering to help pharmaceutical, consumer goods, and agricultural technology organizations shorten research cycles and improve decision making. Its offerings cover next-generation sequencing data management and analysis, cloud-based bioinformatics, biomarker discovery, microarray analysis, and pipeline design, as well as on-demand consulting and tools for managing research data. Headquartered in Cambridge, United Kingdom, with an international footprint, Eagle Genomics emphasizes building an enterprise information architecture for the genomics era, enabling customers to realize the value of digital assets and enhance productivity across R&D programs.

SFH Oxford

Seed Round in 2013
SFH Oxford Ltd. is a UK-based company specializing in the development and marketing of innovative healthcare products aimed at enhancing the management of venous leg ulcers. Founded in 2011 and located in Didcot, the company has created Graducheck, a sensor-based technology that improves the application of compression bandages, thereby increasing healing rates and promoting patient compliance. SFH Oxford also offers anatomic focus technology graduated compression socks, which provide essential graduated compression, and K-gel wound dressings. The company is actively engaged in clinical and field trials for several of its products, which are showing promising results in real-world applications. With a leadership team experienced in medical device technology, wound care, and business development, SFH Oxford is focused on delivering optimized care for patients and healthcare professionals involved in ulcer management.

Keit

Funding Round in 2013
Keit Ltd. is a company specializing in the design and manufacture of advanced spectrometers and related instruments, catering to a wide range of applications from ultraviolet to far infrared rays. Incorporated in 2012 and headquartered in Didcot, United Kingdom, Keit is known for its innovative microFTS® design, a Fourier Transform Infrared (FTIR) spectrometer that is notably smaller, lighter, and more rugged than existing systems. Originally developed for space applications, the microFTS® is capable of operating in extreme environments and sets a new standard for real-time liquid-state analyses across various industries, including Pharmaceutical, Chemical, Oil & Gas, and Food & Beverage. Keit's products are also utilized for measuring signal levels, near line vibrations, and analyzing gas or liquid-borne species.

Igloo Vision

Series A in 2013
Igloo Vision Limited specializes in immersive 360º projection technologies designed for various applications, including simulation, visualization, and collaborative experiences. The company creates virtual reality tools such as media players, software interfaces, projector rigs, and a range of projection environments including domes and cylinders. These immersive spaces allow groups to engage with digital content, making them ideal for entertainment, teamwork, training, and data visualization. Established in 2008 and headquartered in Craven Arms, United Kingdom, Igloo Vision has built a reputation over its decade-long history by collaborating with major global brands and delivering numerous installations and events worldwide. The company's innovative approach transforms any digital content into a shared immersive experience, enhancing the way teams collaborate and visualize complex information.

Cytox

Series A in 2013
Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

Clinical Insights

Seed Round in 2013
Clinical Insights Limited, established in 2012, is a Milan-based company operating as a subsidiary of CMC Consulting Boston Inc. It specializes in providing data analytics and predictive analysis services tailored for healthcare companies, particularly pharmaceutical firms. The company's core offerings include tools and business advisory services that leverage sophisticated analyses of real-time big data to optimize performance, enhance market insights, and improve overall business efficiency. Clinical Insights Limited helps clients uncover hidden product flows, smooth out demand volatility, refine messaging strategies, and gain deeper insights into patient treatment patterns by embedding analytical techniques and proprietary market information into users' management systems. The company maintains offices in Coventry (UK), Milano (Italy), Athens (Greece), and San Gwann (Malta).

Your Vets

Convertible Note in 2012
Your Vets is a UK-based network of veterinary clinics delivering affordable preventive care for pets. The group operates multiple practices across locations including Wythall, Coventry, Nuneaton, Stetchford, Rayleigh and Dagenham, offering vaccinations, neutering and general veterinary services to a broad client base.

ZuvaSyntha

Funding Round in 2012
ZuvaSyntha Limited is an industrial biotechnology company based in Welwyn Garden City, United Kingdom, founded in 2011. The company specializes in developing innovative bio-routes for the production of renewable chemicals from C1 feedstocks. ZuvaSyntha offers a range of contract research and development services, including product and process development, metabolite synthesis, biocatalysis, metabolic pathway engineering, and fermentation. Initially incorporated as BioSyntha Technology Ltd., the company rebranded to ZuvaSyntha Limited in May 2015 and currently operates as a subsidiary of ZuvaChem, Inc.

Your Vets

Convertible Note in 2011
Your Vets is a UK-based network of veterinary clinics delivering affordable preventive care for pets. The group operates multiple practices across locations including Wythall, Coventry, Nuneaton, Stetchford, Rayleigh and Dagenham, offering vaccinations, neutering and general veterinary services to a broad client base.

Igloo Vision

Venture Round in 2011
Igloo Vision Limited specializes in immersive 360º projection technologies designed for various applications, including simulation, visualization, and collaborative experiences. The company creates virtual reality tools such as media players, software interfaces, projector rigs, and a range of projection environments including domes and cylinders. These immersive spaces allow groups to engage with digital content, making them ideal for entertainment, teamwork, training, and data visualization. Established in 2008 and headquartered in Craven Arms, United Kingdom, Igloo Vision has built a reputation over its decade-long history by collaborating with major global brands and delivering numerous installations and events worldwide. The company's innovative approach transforms any digital content into a shared immersive experience, enhancing the way teams collaborate and visualize complex information.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.